Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Brightstar Therapeutics Logo
Brightstar Therapeutics CB Rank
673537
Heat Score
9
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options.
Founded
obfuscation
PrivateSeries A Lexington, Kentucky, United States1-10 www.brightstartx.com
Biotechnology
Health Care
Medical
Therapeutics
Overview

Brightstar Therapeutics
Heat Score
9

Growth Score
pts
in past quarter
Heat Score 9
-14 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Brightstar Therapeutics

CB Rank
673537
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options.
Founded
obfuscation
PrivateSeries A Lexington, Kentucky, United States1-10 www.brightstartx.com
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

BrightMEM Corneal Allograft
A corneal allograft made from Descemet's Membrane, used for transplantation on the ocular surface to treat persistent epithelial defects and limbal stem cell deficiency.
BrightMEM Anterior Keratoplasty (BMAK)
A surgical procedure where the BrightMEM corneal allograft is transplanted onto the ocular surface, providing a substrate for corneal regeneration.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A
obfuscation
Series A - Brightstar Therapeutics Logo
Series A - Brightstar Therapeutics
4
obfuscation
Saving SightSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 2
News
Technology
View Tech Report

Monthly Web Visits

306
-10.26%
 in past month

IT Spend

$34KThis year, Brightstar Therapeutics is projected to spend $34K on IT, according to Aberdeen.

Active Website Tech Count

9Brightstar Therapeutics is actively using 9 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Google Font API.

Total IP

3Brightstar Therapeutics has registered 3 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Brightstar Therapeutics's headquarters? Brightstar Therapeutics is located in Lexington, Kentucky, United States.Who invested in Brightstar Therapeutics? Brightstar Therapeutics has 4 investors including University of Minnesota Discovery Capital Investment and  The North Carolina Eye Bank.When was the last funding round for Brightstar Therapeutics? Brightstar Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are Brightstar Therapeutics's competitors? Alternatives and possible competitors to Brightstar Therapeutics may include BioTissue, Aurion Biotechnologies, and  CorneaGen.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(107690b 1)
|